{
    "organizations": [],
    "uuid": "085e9bed5b9270d0208b150cf886861931c64798",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncobiologics-q1-loss-per-share-07/brief-oncobiologics-q1-loss-per-share-0-71-idUSASB0C5P0",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncobiologics Q1 Loss Per Share $0.71",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 22 PM / in 13 minutes BRIEF-Oncobiologics Q1 Loss Per Share $0.71 Reuters Staff * ONCOBIOLOGICS REPORTS FIRST QUARTER FISCAL YEAR 2018 RESULTS * Q1 LOSS PER SHARE $0.71 * Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.20 * CASH WAS $13.8 MILLION AS OF DECEMBER 31, 2017, COMPARED TO $3.2 MILLION AS OF SEPTEMBER 30, 2017 Source text for Eikon: Further company coverage:",
    "published": "2018-02-14T22:22:00.000+02:00",
    "crawled": "2018-02-14T16:38:49.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "oncobiologics",
        "report",
        "first",
        "quarter",
        "fiscal",
        "year",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "adjusted",
        "loss",
        "per",
        "share",
        "cash",
        "million",
        "december",
        "compared",
        "million",
        "september",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}